ImmuneRegen and University of Rochester to examine Homspera in lethal radiation exposure April 15, 2009 No Comments
Catalyst halts enrollment into phase II trial of CPP-109 for methamphetamine addiction March 6, 2009 No Comments
Aeolus initiates studies of AEOL-10150 as a countermeasure to mustard gas exposure Feb. 11, 2009 No Comments
DOR BioPharma forms medical advisory board to advise on development of DOR-201 Jan. 28, 2009 No Comments
RSS